547 related articles for article (PubMed ID: 28214182)
21. [Immune-related adverse events of immune checkpoint inhibitors].
Tadano H; Torigoe T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):102-108. PubMed ID: 28603200
[TBL] [Abstract][Full Text] [Related]
22. Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation.
Yang H; Yao Z; Zhou X; Zhang W; Zhang X; Zhang F
Clin Immunol; 2020 Apr; 213():108377. PubMed ID: 32135278
[TBL] [Abstract][Full Text] [Related]
23. [No hair loss, but colitis or pneumonitis: unique side effects of immune checkpoint inhibitors for cancer].
Steenbruggen TG; van den Heuvel MM; Blank CU; van Dieren JM; Haanen JB; Kok M
Ned Tijdschr Geneeskd; 2016; 160():A9873. PubMed ID: 27438388
[TBL] [Abstract][Full Text] [Related]
24. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.
Kroschinsky F; Stölzel F; von Bonin S; Beutel G; Kochanek M; Kiehl M; Schellongowski P;
Crit Care; 2017 Apr; 21(1):89. PubMed ID: 28407743
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint inhibitors renal side effects and management.
Rassy EE; Kourie HR; Rizkallah J; Karak FE; Hanna C; Chelala DN; Ghosn M
Immunotherapy; 2016 Dec; 8(12):1417-1425. PubMed ID: 28000536
[TBL] [Abstract][Full Text] [Related]
26. Opportunistic autoimmunity secondary to immunotherapy and melanoma: Back to ABCDE?
Kostine M; Stavris C; Chiche L
Eur J Cancer; 2017 Aug; 81():240-241. PubMed ID: 28434854
[No Abstract] [Full Text] [Related]
27. Toxicity profiles of immunotherapy.
Cousin S; Seneschal J; Italiano A
Pharmacol Ther; 2018 Jan; 181():91-100. PubMed ID: 28716652
[TBL] [Abstract][Full Text] [Related]
28. Understanding adverse events of immunotherapy: A mechanistic perspective.
Burke KP; Grebinoski S; Sharpe AH; Vignali DAA
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601411
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy Toxicities.
Sanchez K; Page DB; Urba W
Surg Oncol Clin N Am; 2019 Jul; 28(3):387-401. PubMed ID: 31079795
[TBL] [Abstract][Full Text] [Related]
30. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
Khan S; Gerber DE
Semin Cancer Biol; 2020 Aug; 64():93-101. PubMed ID: 31330185
[TBL] [Abstract][Full Text] [Related]
31. Immune checkpoint inhibitor therapy-induced hypophysitis ∼ a case series of Taiwanese patients.
Lin CH; Chen KH; Chen KY; Shih SR; Lu JY
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):524-529. PubMed ID: 30104119
[TBL] [Abstract][Full Text] [Related]
32. Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.
Nagai H; Muto M
Int J Clin Oncol; 2018 Jun; 23(3):410-420. PubMed ID: 29516216
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges.
Teng F; Kong L; Meng X; Yang J; Yu J
Cancer Lett; 2015 Aug; 365(1):23-9. PubMed ID: 25980820
[TBL] [Abstract][Full Text] [Related]
34. [The pathology of adverse events with immune checkpoint inhibitors].
Koelzer VH; Glatz K; Bubendorf L; Weber A; Gaspert A; Cathomas G; Lugli A; Zippelius A; Kempf W; Mertz KD
Pathologe; 2017 May; 38(3):197-208. PubMed ID: 28421272
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy is cancer treatment with a novel side-effect profile].
Kondrup M; Raunkilde L; Svane IM; Schmidt H; Bastholt L
Ugeskr Laeger; 2017 Oct; 179(40):. PubMed ID: 28992844
[TBL] [Abstract][Full Text] [Related]
36. Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer.
Bakacs T; Moss RW; Kleef R; Szasz MA; Anderson CC
Scand J Immunol; 2019 Dec; 90(6):e12821. PubMed ID: 31589347
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.
Martins F; Sykiotis GP; Maillard M; Fraga M; Ribi C; Kuntzer T; Michielin O; Peters S; Coukos G; Spertini F; Thompson JA; Obeid M
Lancet Oncol; 2019 Jan; 20(1):e54-e64. PubMed ID: 30614479
[TBL] [Abstract][Full Text] [Related]
38. [Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors].
Faviez G; Bousquet E; Rabeau A; Rouquette I; Collot S; Goumarre C; Meyer N; Prevot G; Mazieres J
Rev Mal Respir; 2018 Nov; 35(9):963-967. PubMed ID: 30220489
[TBL] [Abstract][Full Text] [Related]
39. Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancer.
Sebastiani GD; Scirocco C; Galeazzi M
Autoimmun Rev; 2019 Aug; 18(8):805-813. PubMed ID: 31176871
[TBL] [Abstract][Full Text] [Related]
40. Acute management of autoimmune toxicity in cancer patients on immunotherapy: Common toxicities and the approach for the emergency physician.
Lomax AJ; McNeil C
Emerg Med Australas; 2017 Apr; 29(2):245-251. PubMed ID: 28093870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
